Wanbury Limited — Updates, 27-06-2025: Press Release

Wanbury Ltd has launched Wanbury C RED, a liposomal iron supplement targeting iron-deficiency anemia, with early strong sales in North and South India. The product leverages superior absorption and reduced side effects, especially in pregnant women and children, driving rapid adoption among healthcare professionals. The company is scaling up Pan-India distribution, expecting this formulation to boost revenue and expand its presence in the therapeutic segment. Wanbury’s focus on innovative, clinically endorsed products reaffirms its leadership in the domestic formulation market.